• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall A2376 Extra Supplies Kit

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall A2376 Extra Supplies Kit see related information
Date Initiated by Firm February 06, 2013
Date Posted April 18, 2013
Recall Status1 Terminated 3 on November 25, 2013
Recall Number Z-1131-2013
Recall Event ID 64848
Product Classification System, blood collection, vacuum-assisted, manual - Product Code KST
Product Heritage Labs Path Study Extra Supplies Kit, Product # A 2376, kit contains 3 zippered plastic bags which hold support supplies for health care providers when treating patients. Bag #3 contains 5 different blood collection tubes (5 each) and 2 different gauge needles--all for drawing blood. One of the tubes is the recalled BD blue top citrate tube (5 tubes). These tubes were manufactured by BD, Franklin Lakes, NJ.

The kit is used by health care providers when treating patients.

Code Information Lot A2376-12307, exp 2/28/2013 and Lot A2376-12272, exp 4/30/2013
Recalling Firm/
Heritage Labs International LLC
560 N Rogers Rd
Olathe KS 66062-1211
For Additional Information Contact
Manufacturer Reason
for Recall
The product has a Lithium Heparin contaminant which could adversely affect coagulation results potentially causing erroneous lab results.
FDA Determined
Cause 2
Material/Component Contamination
Action The recalling firm contacted 25 of their 26 customers by phone on February 5, 2013, to notify them of the recall and sent a follow up memo on February 6, 2013, During the call, the firm reminded their customers how many recalled kits they recieved and instructed them to go through the kits and pull the recalled lots. The recalled kits are to be returned to the recalling firm and the firm sent a follow-up memo on February 6, 2013, with the shipping label their customers to place on the returning kit shipping box. This memo was sent to the customers by overnight Fed-ex mail and the ship label for the returned product was an overnight UPS label. On February 7, 2013, the final customer was notified by phone and instructed to return the recalled kits. For further questions please call (913) 764-1045.
Quantity in Commerce 25 kits
Distribution Nationwide Distribution including the states of AL, CA, GA, IL, IN, KY, MA, MD, NC, NY, OK and VA.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.